OpenAlex
PricingAboutJobs
Log inGet started
Work

Inclisiran for the Treatment of Cardiovascular Disease: the Orion Clinical Development Program

HTML

Year: 2018
Type: article
Source: Future Cardiology
DOI: 10.2217/fca-2018-0067
Authors: Robert M Stoekenbroek, David Kallend, Peter LJ Wijngaard, John JP Kastelein
Institutions: Amsterdam UMC Location University of Amsterdam, Medicines Company (United States), University of Amsterdam
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: inclisiran, PCSK9 inhibition, RNA interference, atherosclerotic cardiovascular disease, familial hypercholesterolemia, cardiovascular outcomes, drug safety and tolerability, high-risk patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2899066146
FWCI: 9.827
Cites: 43
Cited by: 115
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security